The Rule Maker purchased five shares in one of the most solid pharmaceutical and consumer products companies in the world -- Johnson & Johnson (NYSE: JNJ). We like the company's brand name, cash flow, pipeline of new drugs, biotechnology products and partnerships, and the economics of the pharmaceutical industry. We discussed the purchase in this an article called, "Rule Maker to Buy J&J" and again in an article called "J&J's Savvy Acqusition."
ACTION # STOCK PRICE COMS'N CASH PAID
Buy 5 Johnson & Johnson $87.30 0 $436.50
